Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/IRCT20240411061470N1
IRCT20240411061470N1CompletedUnknown

Effect of supplementation with type I and type III collagen peptide and type II hydrolyzed collagen on osteoarthritis-related pain, quality of life and physical function: a randomized, double-blind, placebo-controlled study

Ondokuz Mayis University0 sites40 target enrollmentStarted: TBDLast updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Trial Snapshot

Phase
Unknown
Status
Completed
Enrollment
40
Study OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
35 years to 65 years (—)
Sex
All

Inclusion Criteria

  • •Diagnosed with unilateral or bilateral Kellgren and Lawrence radiographic grade 2 or 3 knee OA for more than 3 months
  • •Non-vegetarian
  • •Willing to participate in all scheduled visits and tests

Exclusion Criteria

  • •Kellgren and Lawrence diagnosed with radiographic grade 1 or 4 knee OA
  • •Any history of trauma, fracture or surgery on the index joint
  • •Evidence or history of clinically significant hematologic, renal, endocrine, pulmonary, gastrointestinal, cardiovascular, hepatic, neurologic diseases or malignancies within the last 5 years
  • •History of hypersensitivity to the rescue medication or any of the products used in the study
  • •Active viral or bacterial infection according to clinical examination
  • •Expected knee arthroscopy or arthroplasty or life-threatening pathology
  • •Received intra-articular injections or corticosteroids in the target knee joint (the most painful knee at screening) within the last 6 months
  • •Patients with intolerance to protein-based foods or supplements, pregnant or breastfeeding women and those with alcohol dependence

Investigators

Similar Trials

Completed
Unknown
The effect of collagen-containing supplementation on pain, quality of life and functional parameters in meniscopathy patientsTear of meniscus.Tear of meniscus, current injuryS83.2
IRCT20240411061470N2Ondokuz Mayis University35
Not yet recruiting
Phase 2
Evaluation of the effects of supplementation extract prepared from Capparis spinosa on clinical manifestations in patients with refractory rheumatoid arthritis.Rheumatoid arthritis.Rheumatoid arthritis with rheumatoid factor
IRCT20151028024760N5Mashhad University of Medical Sciences30
Not yet recruiting
Phase 2
A comparative study on efficacy of supplementation of iron syrup and iron rich diet in improving the iron status in children aged 6 to 10 years with mild anemia.
CTRI/2024/03/064010nil
Not yet recruiting
Not Applicable
Investigating the effect of French bark extract, Pycnogenol, as a supplement to improve exercise performance in a population of AFL footballers.exercise performanceAlternative and Complementary Medicine - Other alternative and complementary medicineMusculoskeletal - Normal musculoskeletal and cartilage development and function
ACTRN12622000435785a Trobe University40
Not yet recruiting
Not Applicable
Investigating the effect of French bark extract, Pycnogenol, as a supplement to improve exercise performance in a population of cyclists.
ACTRN12622000517774a Trobe University20